Skip to main content
. Author manuscript; available in PMC: 2009 Sep 29.
Published in final edited form as: Am J Obstet Gynecol. 2007 Oct;197(4):396.e1–396.e9. doi: 10.1016/j.ajog.2007.07.020

Figure 5.

Figure 5

Despite the differences observed in recipient fetal mortality, there were no statistically significant differences in overall survival to 30 days of age. The reason was that while there were more fetal recipient deaths in the SFLP arm than in the AR arm of the study, more recipients were declared treatment failures in the AR arm (7 of 20), versus the SFLP arm (0 of 20). Neonatal death occurred in 6 of the 7 cases declared treatment failures.